Lipocine Inc. (LPCN) Earnings History
Annual and quarterly earnings data from 2011 to 2025
Loading earnings history...
LPCN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LPCN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | -334.3% | -524.7% | -487.1% |
| 2024 | 100.0% | -10.3% | 0.1% |
| 2023 | - | - | - |
| 2022 | -1611.4% | -2423.9% | -2151.7% |
| 2021 | 52.5% | 19.5% | -3.9% |
Download Data
Export LPCN earnings history in CSV or JSON format
Free sign-in required to download data
Lipocine Inc. (LPCN) Earnings Overview
As of May 8, 2026, Lipocine Inc. (LPCN) reported trailing twelve-month net income of -$11M. The company earned $-1.68 per diluted share over the past four quarters, with a net profit margin of -487.1%.
Looking at the long-term picture, LPCN's historical earnings data spans multiple years. The company achieved its highest annual net income of $4M in fiscal 2012.
Lipocine Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ANIP ($78M net income, 8.9% margin), TLSA (-$34M net income), NUVB (-$146M net income, -325.3% margin), LPCN has room to improve margins relative to the peer group. Compare LPCN vs ANIP →
LPCN Earnings vs Peers
Earnings metrics vs comparable public companies
LPCN Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$10M | -115371.9% | -$10M | $-1.69 | -487.1% | -524.7% |
| 2024 | $8,352 | +100.1% | -$1M | $-0.00 | 0.1% | -10.3% |
| 2023 | -$16M | -52.0% | -$18M | $-3.14 | - | - |
| 2022 | -$11M | -1595.9% | -$12M | $-2.05 | -2151.7% | -2423.9% |
| 2021 | $-634,399 | +97.0% | $3M | $-0.12 | -3.9% | 19.5% |
| 2020 | -$21M | -61.2% | -$18M | $-6.40 | - | - |
| 2019 | -$13M | -11.6% | -$13M | $-8.54 | -7883.7% | -7818.8% |
| 2018 | -$12M | +44.4% | -$11M | $-9.28 | -2724.1% | -2646.0% |
| 2017 | -$21M | -10.6% | -$21M | $-17.85 | - | - |
| 2016 | -$19M | -4.2% | -$18M | $-17.68 | - | - |
See LPCN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LPCN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LPCN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLPCN — Frequently Asked Questions
Quick answers to the most common questions about buying LPCN stock.
Is LPCN growing earnings?
LPCN TTM EPS: $-1.68. Net income: $-11M. Earnings growth: N/A.
What are LPCN's profit margins?
Lipocine Inc. net margin is -487.1%, with operating margin at -524.7%. Below-average margins reflect competitive or cost pressures.
How consistent are LPCN's earnings?
LPCN earnings data spans 2011-2025. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.